Capital Market Shri Vijay Kedia
1:53:00
VIPCA Digital Pathshala - Day 4
1:33:40
VIPCA Digital Pathshala - Day 3
1:44:01
Become part of VIPCA Pariwar
4:21
2 жыл бұрын
Пікірлер
@RaviShankarGoyal
@RaviShankarGoyal 22 күн бұрын
Thanks for your wonderful presentation and knowledge
@uma11977
@uma11977 Ай бұрын
thanks. Very informative.
@kushalchowdhary4279
@kushalchowdhary4279 7 ай бұрын
Can you share the PPT
@amarnathsingla1224
@amarnathsingla1224 8 ай бұрын
Book profit means stop profit ?😊
@amarnathsingla1224
@amarnathsingla1224 8 ай бұрын
Stop loss means book loss
@niket002
@niket002 9 ай бұрын
Thankyou for this great video. Can we please get the excel file? Thanks
@alihassan-bv3ph
@alihassan-bv3ph 11 ай бұрын
Sir can you share a practice file
@roxyroxy7671
@roxyroxy7671 Жыл бұрын
छtalking with fund mangers will result u as fund mangers.....
@heenazaveri9632
@heenazaveri9632 Жыл бұрын
good evening, i want this templet sheet
@DevendraKumar-ob6hd
@DevendraKumar-ob6hd Жыл бұрын
Dear sir Financial statements read kar lijiye ca log to VIP road ca par chartered accountant log kab se wrong investment idea dene lage retail investors ko. good advise nhi dene aata to wrong advise nahi dijiye kisi ko.
@renganseshadri
@renganseshadri Жыл бұрын
When I select quiery to be closed and loaded, closing balance for all rows are blank
@akashbiradar2712
@akashbiradar2712 Жыл бұрын
5:00
@KundanKumar-kk2wk
@KundanKumar-kk2wk Жыл бұрын
Sir aaplog ase program kar Kay hum jse samnya logo pay bhut meharbani kartay hai 🙏
@arnabbhattacharya6579
@arnabbhattacharya6579 Жыл бұрын
Actual thing start around 8.30 minutes
@divanshkondinya
@divanshkondinya Жыл бұрын
how bonus shares will be taxed after conversion into LLP, If LLP is dissolving
@shivagore9313
@shivagore9313 Жыл бұрын
Important Part Starts at 05.00
@kansingh5968
@kansingh5968 Жыл бұрын
Nice
@biganna99
@biganna99 2 жыл бұрын
AY 2013-14/14-15 cases will fall within the 10 year criterion and hence they shall be reassessed... See that. ITD has yet to interpret this judgement in it's own way..
@milindbidve8250
@milindbidve8250 2 жыл бұрын
Piyush sir you are the best
@siddhucool2003
@siddhucool2003 2 жыл бұрын
छा गये सर जी
@milindbidve8250
@milindbidve8250 2 жыл бұрын
Superb guidence piyush sir
@MostafizurRahman-bv5eu
@MostafizurRahman-bv5eu 2 жыл бұрын
Can I get Kapil Sir's contact details
@vinayshah1042
@vinayshah1042 2 жыл бұрын
Virendar Bansal grilled the panelist very well. LOL
@vinayshah1042
@vinayshah1042 2 жыл бұрын
I would like to thank VIP Road Chartered Accountants study circle for bringing Mr. Piyush Patel in the panel. One of the best guru/teacher/analyst. His knowledge is deep and excellent. He guided many newbies like me and many others. The way he explained concepts in very simple language so anyone can understand.
@meditationandhealingmusic5684
@meditationandhealingmusic5684 2 жыл бұрын
If some prosecution pending against company under income tax act then conversion possible pvt ltd into llp
@vashjakhar1177
@vashjakhar1177 2 жыл бұрын
No
@ashaagarwal4183
@ashaagarwal4183 3 жыл бұрын
COMPLEX LAW OF GST EXPLAINED IN A SIMPLE WAY.
@ramakantasopa3921
@ramakantasopa3921 3 жыл бұрын
Can I get Kapil Sir drafted 3nos. pdf reply?
@caprakashdshah8633
@caprakashdshah8633 2 жыл бұрын
For 148 draft letter
@vivekmalik6714
@vivekmalik6714 3 жыл бұрын
Can we talk
@gulamjilani6945
@gulamjilani6945 3 жыл бұрын
Old site ko hi resume kr do please 🙏 Tumse na ho payega- new incometax website
@h4hiten
@h4hiten 3 жыл бұрын
6:32 Residential status
@dedetarrah144
@dedetarrah144 3 жыл бұрын
0:41 vow.fyi
@manireddy869
@manireddy869 3 жыл бұрын
Please share the excel file
@aakashsharma9218
@aakashsharma9218 3 жыл бұрын
From where i can get the Excel Sheet???
@cakbhalotia
@cakbhalotia 3 жыл бұрын
I feel speaker had a good but unstructured content. Deliberation in hinglish would have been more effective. Not criticism but constructive feedback.
@deepakchutani5967
@deepakchutani5967 3 жыл бұрын
Excellent sir.. you are a young Chartered Accountant
@mohitpathak1416
@mohitpathak1416 3 жыл бұрын
Limit of RS.10,000.00 is applicable on purchasing of capital asset of charitable trust or not.
@meghashivakumar1560
@meghashivakumar1560 3 жыл бұрын
Yes waiting for the Excel sheets shown by premnath sir!
@mangalahampasagar
@mangalahampasagar 3 жыл бұрын
Please share link to download excel sheet provided by Premanath sir
@tianadsouza1164
@tianadsouza1164 3 жыл бұрын
Very useful sessions
@shoaib8861
@shoaib8861 3 жыл бұрын
I want to extract data in format of opening bal, Debit,credit,closing balance.I got the opening field in ODBC but could not found debit and credit can some body please help me
@ashishmishra6972
@ashishmishra6972 3 жыл бұрын
Pls mam, share the excel sheet
@omnamahshivay970
@omnamahshivay970 4 жыл бұрын
@4:48 NRI thing
@caorugantisridhar3169
@caorugantisridhar3169 4 жыл бұрын
Good initiative sir, thank you
@studyiqchannel3520
@studyiqchannel3520 4 жыл бұрын
I am a lawyer and I had the very same opinion.I have a suggestion to all my dear law students: The more you study law bare acts,the more u will get confused so directly jump into practise and learn only what is requred in practise.
@lahaa53
@lahaa53 4 жыл бұрын
COVID19 and Ivermectin High population density plus unlocking lead to community transmission, resulting in fast increase in the number of COVID19 cases in India. Good news is that, large number of infected persons would be cured of the disease without much symptoms; these asymptomatic persons would not subject themselves to any form of testing or treatment; they would roam freely in society and would infect more persons - and this would usher in HERD IMMUNITY in India. Patients with mild-to-moderate symptoms do not require costly indoor treatment; and such patients should be treated by doctors at the periphery; and the doctors should treat these patients based on clinical assessments of the patients - elaborate testing, to exclude COVID19, for each and every persons suffering from fever with mild-to-moderate Flu-like symptoms is a very costly proposition. There would be severe forms of chaos if we try to cater indoor treatment to all symptomatic patients presenting with mild-to-moderate Flu-like features. However, severely ill patients, aged patients with comorbidities should be admitted in well-equipped institutions. ICMR should allow doctors, not attached to any state-run hospital or private institution, to treat patients with mild-to-moderate Flu-like symptoms with a cocktail of drugs - Vitamin D, Vitamin C, Zinc, Azithromycin and Ivermectin. Doctors attached to state-run or private institutions are, I think, already instructed by ICMR about management of such patients at indoor and outdoor. COVID19 is a Global emergency; we do not have much time for elaborate clinical trials (multi-centric, double-blind, placebo-controlled, above all, reports should be acceptable to peer-group-reviewed international Journals) to prove or disprove efficacy of Ivermectin in treating COVID19. Doctors of many nations have published reports proving excellent efficacy of Ivermectin; no doubt, these studies have been conducted with a small number of patients; but still, we cannot discard the inferences of these reports out right, because these findings are collected by senior physicians with long experiences in clinical medicine. Arun Kumar Laha 09 06 2020 < [email protected] > IVERMECTIN Times Of India published two reports on 21st and 22th May praising Rendesivir and Favipiravir, two antivirals. Mainstream media worldwide are promoting these drugs of big pharma companies; however, most, if not all, antivirals are of questionable efficacy. No one is promoting IVERMECTIN, a cheap oral drug, prescribing which against COVID19 doctors from many nations, including Bangladesh, got EXCELLENT results. No one is interested in promoting this off patented molecule. Scientists could not fabricate vaccines against all and every pathogenic Virus; most probably, COVID19 is one of such type. Monoclonal antibody against viral proteins, however, is a good treatment plan. NO MASK, NO SOCIAL DISTANCING, NO LOCKDOWN, WILL BE ABLE TO SAVE HUMANITY FROM COVID19. IVERMECTIN, HCQ AND HERD IMMUNITY DUE TO SUBCLINICAL INFECTION IN COMMUNITY AT LARGE WOULD SAVE US. Fight against COVID19 To fight against COVID19 India has to chalk out her own plan; we should not ape other nations. There would be serious socio-economic disaster in India if we continue total or partial lockdown. Most of the COVID19 infected patients in India are asymptomatic; and this might be due to the presence of Curcumin in our daily food. So, it is very difficult to determine patient- load in India; we can not test for COVID19 in all persons under the Sun. Asymptomatic persons would refuse testing and any form of treatment - they would roam freely in society; and would infect the population at large; and this will in near future usher in HERD IMMUNITY in India. Most of the symptomatic patients present with mild to moderate illness; we should treat them as OPD patients. We have to treat these patients with mild-to-moderate Flu-like symptoms as quickly as possible; so that they do not become severely ill to overwhelm the scarce indoor facilities in our country. Here is a safe outdoor treatment plan that will show quick and effective response in symptomatic patients (for adults): - Vitamin D & C and Zinc daily in usual recommended doses + Virostatic drug Ivermectin 12mg daily for 3 to 5 days + Senolytic antibiotic Azithromycin 250mg to 500mg daily for 5 days to 10 days. This treatment plan ushers in prompt response. Serious indoor patients would get these medicines + necessary supportive measures + Hydroxychloroquine (HCQS). - Arun Kumar Laha 29, Abinash Banerjee Lane. Howrah 711104. ([email protected]) Disclaimer: - This is not a prescription for the general public to self- medicate themselves. It is for the medical fraternity to think about my humble suggestion. To solve the problems of COVID 19, lockdown is not the only way out; we have to rely on development of HERD IMMUNITY by exposing people to low grade infection with COVID19 and we have to treat the symptomatic patients as fast as possible, to cut short the number of serious patients requiring indoor treatment. Many health- care personnel and other fighters against COVID19 are losing their lives to save humanity at large; ICMR should think about prescribing IVERMECTIN (12mg in empty stomach once in a week instead of Hydroxychloroquine) to these persons. Ivermectin is safer than Hydroxychloroquine.
@Ashishsh1980
@Ashishsh1980 4 жыл бұрын
Plz share link for income tax changes 20-21 & capital Gain
@Ashishsh1980
@Ashishsh1980 4 жыл бұрын
Nice sirji
@taxationtalk8049
@taxationtalk8049 4 жыл бұрын
Girish Ahuja sir is the ocean of knowledge #taxationtalk
@Amitkhatri9002
@Amitkhatri9002 4 жыл бұрын
Girish Ahuja sir....as adorable as always . Thank you sir 🙏
@ratnamanikyalaraobhogi9453
@ratnamanikyalaraobhogi9453 4 жыл бұрын
Sir Kindly give your deliberations in English so that large number of our members will get this advantage, thank you sir